Moisand Fitzgerald Tamayo’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.9K Hold
49
﹤0.01% 292
2026
Q1
$14.3K Hold
49
﹤0.01% 302
2025
Q4
$17.2K Hold
49
﹤0.01% 290
2025
Q3
$15.8K Hold
49
﹤0.01% 303
2025
Q2
$19.1K Hold
49
﹤0.01% 281
2025
Q1
$21.3K Hold
49
﹤0.01% 267
2024
Q4
$18.1K Hold
49
﹤0.01% 278
2024
Q3
$25.5K Hold
49
﹤0.01% 259
2024
Q2
$26.6K Hold
49
﹤0.01% 220
2024
Q1
$25.4K Hold
49
﹤0.01% 222
2023
Q4
$23.1K Hold
49
﹤0.01% 245
2023
Q3
$21.3K Hold
49
﹤0.01% 254
2023
Q2
$21.8K Hold
49
﹤0.01% 243
2023
Q1
$22.5K Hold
49
﹤0.01% 246
2022
Q4
$25.1K Buy
49
+18
+58% +$9.14K 0.01% 226
2022
Q3
$14K Buy
+31
New +$14.8K ﹤0.01% 255
2018
Q1
Sell
-14
Closed -$3K 326
2017
Q4
$3K Hold
14
﹤0.01% 235
2017
Q3
$3K Buy
+14
New +$2.67K ﹤0.01% 256

Other funds holding ELV

Moisand Fitzgerald Tamayo's ELV Position: Q2 2026 in Review

Moisand Fitzgerald Tamayo held its Elevance Health (ELV) position steady in Q2 2026 at 49 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #292.

Moisand Fitzgerald Tamayo first reported a position in ELV in Q3 2017 and has held it in 18 quarters since. The position peaked at $26.6K in Q2 2024. 368 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Moisand Fitzgerald Tamayo held 49 shares of Elevance Health worth $18.9K as of Q2 2026.
  • Moisand Fitzgerald Tamayo left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up ﹤0.01% of Moisand Fitzgerald Tamayo's portfolio in Q2 2026, its #292 holding.
  • Moisand Fitzgerald Tamayo first reported a position in Elevance Health in Q3 2017 and has held it in 18 quarters since.
  • Moisand Fitzgerald Tamayo's Elevance Health position peaked at $26.6K in Q2 2024.
  • 368 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q2 2026, filed 13 Jul 2026.